{"data":{"id":"us/21-cfr-516.14","jurisdiction":"us","citation":"21 CFR 516.14","heading":"Submission of requests for designation.","body":"All correspondence relating to a request for designation of a MUMS drug must be addressed to the Director of the Office of Minor Use and Minor Species Animal Drug Development. Submissions not including all elements specified in § 516.20 will be returned to the sponsor without review.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES","Subpart B—Designation of a Minor Use or Minor Species New Animal Drug"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"e286a7a6e58aa5077617948909c2d1fed257bc05395c48a7566acf88ddbf7abb","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-516.13","next":"us/21-cfr-516.16"},"notice":"GroundRules: Original legal text. Not legal advice."}